Results 81 to 90 of about 130,207 (296)

The Hidden Link between Polycystic Ovary Syndrome and Kidney Stones: Finding from the Tehran Lipid and Glucose Study (TLGS)

open access: yesDiagnostics, 2023
Background: We aimed to investigate the association between kidney stones and polycystic ovarian syndrome (PCOS). Materials and methods: In a cross-sectional study, data from the Tehran Lipid and Glucose Study (TLGS) were used to investigate the risk of ...
Marzieh Rostami Dovom   +5 more
doaj   +1 more source

Impact of contraception and IVF hormones on metabolic, endocrine, and inflammatory status [PDF]

open access: yes, 2020
Assisted reproductive technologies (ART) represent commonly utilized management strategies for infertility with multifactorial causes (including genetically predisposed diseases). Amongst ART, in vitro fertilization (IVF) is the most popular.
Barber, Thomas M.   +2 more
core   +1 more source

Nutritional Management in Polycystic Ovary Syndrome: Challenges and opportunities [PDF]

open access: yes, 2021
PCOS is one of the most common endocrine diseases affecting women of reproductive age. Its etiology remains unresolved but it is thought to have a genetic basis as well as interactions with other environmental factors.
Ghazeeri, G.   +5 more
core   +1 more source

Identification of Compound Heterozygous CYP11A1 Variants via Reanalysis of Clinical Sequencing Data

open access: yesAmerican Journal of Medical Genetics Part A, EarlyView.
ABSTRACT A molecular diagnosis is currently achievable in approximately 50% of patients assessed by clinical geneticists at tertiary care centres. Next‐Generation Sequencing Panels contain a defined group of genes associated with a clinically defined set of phenotypes.
Ana Acosta Bedón   +10 more
wiley   +1 more source

Combined oral contraceptives: the optimal range of examination. Part 2

open access: yesMìžnarodnij Endokrinologìčnij Žurnal, 2018
Combined oral contraceptives are effective drugs for contraception and treatment of reproductive disorders in polycystic ovarian syndrome. The article considers the main laboratory algorithms for excluding the most common endocrine diseases, the clinical
O.V. Rykova
doaj   +1 more source

Antral follicle count and anti-Müllerian hormone level as predictors of ovarian hyperstimulation syndrome in women with polycystic ovarian syndrome undergoing controlled ovarian stimulation

open access: yesJournal of Ultrasonography, 2021
Aim: To compare the rate of ovarian hyperstimulation syndrome in women with and without polycystic ovarian syndrome, and to determine the cut-off for the antral follicle count and the anti-Müllerian hormone level predictive of ovarian hyperstimulation ...
Izhar Rubina   +5 more
doaj   +1 more source

Apigenin exerts protective effect and restores ovarian function in dehydroepiandrosterone induced polycystic ovary syndrome rats: a biochemical and histological analysis

open access: yesAnnals medicus, 2022
Background Polycystic ovarian syndrome (PCOS) is one of the major causes encouraging the elevation of androgens, obesity along with menstrual complications. Here we study the effect of Apigenin in rat model of polycystic ovarian syndrome.
Fangxin Peng   +4 more
semanticscholar   +1 more source

Longitudinal Behavior Phenotype Hallmarks in RNU4‐2 Syndrome: Implications for Clinical Management

open access: yesAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, EarlyView.
ABSTRACT Pathogenic variants in the non‐coding spliceosomal gene RNU4‐2 underlie ReNU syndrome, one of the most prevalent monogenic causes of neurodevelopmental disorders, accounting for ~0.4% of cases. Despite increasing recognition, little is known about the longitudinal behavioral and neuropsychiatric phenotype of affected individuals. We report two
Paola Francesca Ajmone   +8 more
wiley   +1 more source

The Endometrial Thickness in Infertile Women with Polycystic Ovarian Syndrome

open access: yesDiyala Journal of Medicine, 2018
Background: The polycystic ovarian syndrome is a common cause of infertility and responsible for many changes in endocrine and metabolic activities with a possible role in changing the endometrial thickness.
Yusra Abdulmahdi Hussein   +1 more
doaj   +2 more sources

Diabetes insipidus in a patient with PCOS treated with Depo-Provera

open access: yesEndocrinology, Diabetes & Metabolism Case Reports, 2022
Depot medroxyprogesterone acetate, also known as Depo-Provera, is a progesterone-only contraceptive that is administered by injection to patients every three months.
Amanda I Martinez, Nicholas Mezitis
doaj   +1 more source

Home - About - Disclaimer - Privacy